Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
973K
-
Shares change
-
-104K
-
Total reported value, excl. options
-
$151M
-
Value change
-
-$16.2M
-
Number of buys
-
28
-
Number of sells
-
-39
-
Price
-
$155.73
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q3 2023
120 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q3 2023.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 973K shares
.
Largest 10 shareholders include Miller Investment Management, LP (176K shares), GOLDMAN SACHS GROUP INC (114K shares), MORGAN STANLEY (67.3K shares), JPMORGAN CHASE & CO (59.5K shares), BANK OF AMERICA CORP /DE/ (53.3K shares), LPL Financial LLC (43.1K shares), Consolidated Investment Group LLC (29.7K shares), COMMONWEALTH EQUITY SERVICES, LLC (28.7K shares), UBS Group AG (27.1K shares), and Royal Bank of Canada (24.8K shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.